A Phase 2 interventional study of Dentifrices in Plaque, Dental, sponsored by Church & Dwight Company, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-12.
Sponsored by Church & Dwight Company, Inc. · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Dental Plaque with a site in United States — 7 open to participants now, 8 under way, 1 of them phase 3. Dental Plaque · United States.
Among the 65 studies in Dental Plaque with a site in United States, this one is the 35th largest by enrollment of the 59 interventional ones that give a count, is one of 4 that started in 2020, is one of 5 in phase 2, and was the 38th registered.
352 studies on the registry are indexed under Dental Plaque; 60 are open to participants now.
Browse Dental Plaque studies →7 of the 65 studies in Dental Plaque with a site in United States are open now. Recruiting first, the newest first:
Flaus, Inc · Sites in United States
Ages 18–70 · Healthy volunteers
The University of Texas Health Science Center at San Antonio · Sites in United States
Ages 18–70
Lactea Therapeutics, LLC · Sites in United States
Ages 18–65 · Healthy volunteers
University of Nebraska · Sites in United States
Ages 19–85 · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18–85 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 35 Dental Plaque studies recruiting now, 10 (29%) set no upper age limit and 20 (57%) stop at 75 or younger; 14 take children under 18; 22 take healthy volunteers.
This study: 18 Years to 69 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 5 · Phase 3 12 · Phase 4 4
First in 1998; this study’s year is marked. 4 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 70 is above the median of 56 across 316 interventional studies indexed under Dental Plaque.
Median enrollment 80 across the 59 interventional studies, 122 across the 6 observational. Of the 57 that completed or were terminated, 26 (46%) have results posted.
This tab as a report to print or save as PDF → With an account.
43 of 65 have an industry lead sponsor. The 10 most frequent:
Church & Dwight Company, Inc. is the lead sponsor of 33 studies on the registry; none are open to participants now.
Church & Dwight Company, Inc. has 5 studies filed under Dental Plaque — fewer than ten, so there is no comparison to draw.
3 of the studies in Dental Plaque with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07605338Phase 3Colgate PalmoliveTo Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis. | 2026-11 |
| NCT07706647The University of Texas Health Science Center at San AntonioOil Pulling Reduction | 2026-11-30 |
| NCT05384132University of Alabama at BirminghamNovel Dental Gel as an Adjunct to Scaling and Root Planing | 2027-10-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 65 studies in Dental Plaque with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate and compare plaque removal efficacy of four dentifrices following a single timed tooth brushing. Prior to each evaluation visit of the four-way cross-over study, subjects will abstain from all oral hygiene for 24 hours. At each evaluation visit, subjects will be given a pre-brushing plaque evaluation, followed by a 1-minute supervised brushing and a post-brushing plaque evaluation.
This study is a randomized, single-brushing, examiner-blinded, 4-cell cross-over design that enrolled approximately 70 subjects to ensure that at least 60 subjects to complete the study. This 4-week cross-over study will evaluate plaque removal following a single brushing with the assigned dentifrices. Qualified subjects will have sufficient plaque (Lobene-Soparkar Modification of Turesky Plaque Index). Subjects will be given a pre-brushing plaque evaluation, followed by a 1-minute supervised brushing and a post-brushing plaque evaluation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Toothpaste with Stannous Fluoride
Drug: Dentifrices
Toothpaste with Sodium Fluoride and sodium bicarbonate
Drug: Dentifrices
Toothpaste with Stannous Fluoride
Drug: Dentifrices
Toothpaste with sodium Fluoride and sodium bicarbonate
Drug: Dentifrices
Dentifrice on plaque
Mean change from baseline (pre-brushing to post-brushing) in plaque score after single supervised use based on all surfaces of the whole mouth measured.
plaque evaluation
Time frame: up to 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Nov 2020 to primary completion in Dec 2020, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dentifrices
Church & Dwight Company, Inc. →